Soluble CD40 Ligand Stimulates CD40-Dependent Activation of the β2 Integrin Mac-1 and Protein Kinase C Zeda (PKCζ) in Neutrophils: Implications for Neutrophil-Platelet Interactions and Neutrophil Oxidative Burst

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Jin, Rong ^a   Yu, Shiyong ^a,c   Song, Zifang ^a   Zhu, Xiaolei ^a   Wang, Cuiping ^a,d   Yan, Jinchuan ^d   Wu, Fusheng ^e   Nanda, Anil ^a   Granger, D Neil ^b   Li, Guohong ^a,b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^e ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C ZETA; SOLUBLE CD40 LIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RESPIRATORY BURST; THROMBOCYTE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTIGENS, CD40; BLOOD PLATELETS; CD40 LIGAND; CELL ADHESION; CELL COMMUNICATION; CELLS, CULTURED; MACROPHAGE-1 ANTIGEN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST; SIGNAL TRANSDUCTION; TRANSCELLULAR CELL MIGRATION; TRANSCRIPTION FACTOR RELA;

EID: 84878779758     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064631     Document Type: Article

References (37)

1. Massberg S, Brand K, Gruner S, Page S, Muller E, et al. (2002) A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196: 887-896.
2. Shah PK, (2003) Inflammation, neointimal hyperplasia, and restenosis: as the leukocytes roll, the arteries thicken. Circulation107: 2175-2177.
3. Welt FG, Rogers C, (2002) Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 22: 1769-1776.
4. Roque M, Fallon JT, Badimon JJ, Zhang WX, Taubman MB, et al. (2000) Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol 20: 335-342.
5. Osaka M, Hagita S, Haraguchi M, Kajimura M, Suematsu M, et al. (2007) Real time imaging of mechanically injured-femoral artery in mouse revealed a biphasic pattern of leukocyte accumulation. Am J Physiol Heart Circ Physiol 292: 1876-1882.
6. Neumann FJ, Ott I, Gawaz M, Puchner G, Schomig A, (1996) Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. J Am Coll Cardiol 27: 819-824.
7. Inoue T, Uchida T, Yaguchi I, Sakai Y, Takayanagi K, et al. (2003) Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis. Circulation 107: 1757-1763.
8. Inoue T, Kato T, Hikichi Y, Hashimoto S, Hirase T, et al. (2006) Stent-induced neutrophil activation is associated with an oxidative burst in the inflammatory process, leading to neointimal thickening. Thromb Haemost 95: 43-48.
9. Inoue T, Sakai Y, Hoshi K, Yaguchi I, Fujito T, et al. (1998) Lower expression of neutrophil adhesion molecule indicates less vessel wall injury and might explain lower restenosis rate after cutting balloon angioplasty. Circulation 97: 2511-2518.
10. Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, et al. (1996) Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 28: 1127-1233.
11. Bienvenu JG, Tanguay JF, Chauvet P, Merhi Y, (2001) Relationship between platelets and neutrophil adhesion and neointimal growth after repeated arterial wall injury induced by angioplasty in pigs. J Vasc Res 38: 153-162.
12. Tanguay JF, Hammoud T, Geoffroy P, Merhi Y, (2003) Chronic platelet and neutrophil adhesion: a causal role for neointimal hyperplasia in in-stent restenosis. J Endovasc Ther 10: 968-977.
13. Hassan GS, Merhi Y, Mourad W, (2012) CD40 ligand: a neo-inflammatory molecule in vascular diseases. Immunobiology 217: 521-532.
14. André P, Prasad KS, Denis CV, He M, Papalia JM, et al. (2002) CD40L stabilizes arterial thrombi by a beta3 integrin - dependent mechanism. Nat Med 8: 247-252.
15. Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR, (2002) Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106: 896-899.
16. Li G, Sanders JM, Bevard MH, Sun Z, Chumley JW, et al. (2008) CD40 ligand 13omotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury. Am J Pathol 172: 1141-1152.
17. Hristov M, Gümbel D, Lutgens E, Zernecke A, Weber C, (2010) Soluble CD40 ligand impairs the function of peripheral blood angiogenic outgrowth cells and increases neointimal formation after arterial injury. Circulation 121: 315-324.
18. Diacovo TG, Roth SJ, Buccola JM, Bainton DF, Springer TA, (1996) Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood 88: 146-157.
19. Song Z, Jin R, Yu S, Nanda A, Granger DN, et al. (2012) Crucial role of CD40 signaling in vascular wall cells in neointimal formation and vascular remodeling after vascular interventions. Arterioscler Thromb Vasc Biol 32: 50-64.
20. Simon DI, Dhen Z, Seifert P, Edelman ER, Ballantyne CM, et al. (2000) Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty. J Clin Invest105: 293-300.
21. Mazzei GJ, Edgerton MD, Losberger C, Lecoanet-Henchoz S, Graber P, et al. (1995) Recombinant soluble trimeric CD40 ligand is biologically active. J Biol Chem 270: 7025-7028.
22. Davidson DC, Hirschman MP, Sun A, Singh MV, Kasischke K, et al. (2012) Excess Soluble CD40L Contributes to Blood Brain Barrier Permeability In Vivo: Implications for HIV-Associated Neurocognitive Disorders. PLoS One 7: e51793.
23. Beland JL, Adler H, Del-Pan NC, Kozlow W, Sung J, et al. (1998) Recombinant CD40L treatment protects allogeneic murine bone marrow transplant recipients from death caused by herpes simplex virus-1 infection. Blood 92: 4472-4478.
24. Yacoub D, Hachem A, Théorêt JF, Gillis MA, Mourad W, et al. (2010) Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-associated factor-2/Rac1/p38 mitogen-activated protein kinase signaling pathway. Arterioscler Thromb Vasc Biol 30: 2424-2433.
25. Pamukcu B, Lip GY, Snezhitskiy V, Shantsila E, (2011) The CD40-CD40L system in cardiovascular disease. Ann Med 43: 331-340.
26. Chakrabarti S, Patel KD, (2008) The atypical zeta (zeta) isoform of protein kinase C regulates CD11b/CD18 activation in human neutrophils. Microcirculation15: 555-567.
27. Laudanna C, Mochly-Rosen D, Liron T, Constantin G, Butcher EC, (1998) Evidence of zeta protein kinase C involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis. J Biol Chem 273: 30306-30315.
28. Sun R, Gao P, Chen L, Ma D, Wang J, et al. (2005) Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Res 65: 1433-1441.
29. McDonald PP, Bald A, Cassatella MA, (1997) Activation of the NF-kappaB pathway by inflammatory stimuli in human neutrophils. Blood 89: 3421-3433.
30. Antoniades C, Bakogiannis C, Tousoulis D, Antonopoulos AS, Stefanadis C, (2009) The CD40/CD40 ligand system: linking inflammation with atherothrombosis. J Am Coll Cardiol 54: 669-677.
31. Lievens D, Eijgelaar WJ, Biessen EA, Daemen MJ, Lutgens E, (2009) The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thromb Haemost 102: 206-214.
32. Song Z, Jin R, Yu S, Rivet JJ, Smyth SS, et al. (2011) CD40 is essential in the upregulation of TRAF proteins and NF-kappaB-dependent proinflammatory gene expression after arterial injury. PLoS One 6: e23239.
33. Zarbock A, Polanowska-Grabowska RK, Ley K, (2007) Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev 21: 99-111.
34. Evangelista V, Manarini S, Rotondo S, Martelli N, Polischuk R, et al. (1996) Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the beta 2 integrin CD11b/CD18. Blood 88: 4183-4194.
35. Sergeant S, McPhail LC, (1997) Opsonized zymosan stimulates the redistribution of protein kinase C isoforms in human neutrophils. J Immunol 159: 2877-2885.
36. Sanguigni V, Ferro D, Pignatelli P, Del Ben M, Nadia T, et al. (2005) CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia. J Am Coll Cardiol 45: 35-42.
37. McDonald PP, Bald A, Cassatella MA, (1997) Activation of the NF-kappaB pathway by inflammatory stimuli in human neutrophils. Blood 89: 3421-3433.